Quality of Recovery After Dexamethasone, Ondansetron or Placebo Intrathecal Morphine Administration
Status:
Completed
Trial end date:
2019-11-04
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate not only the occurrence of side effects, but the quality
of the recovery (QoR-40 Questionnaire) of patients submitted to spinal anesthesia with
administration of low doses (0.1 mg) of intrathecal morphine for the surgical treatment of
fractures in one of the lower limbs and who will receive prophylactic ondansetron (4mg),
dexamethasone (8mg) or placebo.